{"title":"Deep learning neural network of adenocarcinoma detection in effusion cytology.","authors":"Katsuhide Ikeda, Nanako Sakabe, Kenta Fukuda, Shouichi Sato, Toshiaki Hara, Harumi Kobayashi, Masato Nakaguro, Kennosuke Karube, Kohzo Nagata","doi":"10.1093/ajcp/aqaf067","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Cytologic examination, which confirms the presence or absence of malignant cells, detects malignant cells from various organs, with adenocarcinoma as the most common histologic type. We developed a deep learning model to detect malignant cells in images obtained following effusion cytology.</p><p><strong>Methods: </strong>The deep learning model was created using the YOLOv8 object detection algorithm (Roboflow, Inc) and 275 cases of adenocarcinoma comprising 12 182 images and 29 245 labels as well as 188 cases negative for malignancy comprising 1980 images.</p><p><strong>Results: </strong>The adenocarcinoma test dataset exhibited Precision, Recall, F1, and mean average Precision scores of 0.909, 0.911, 0.910, and 0.955, respectively. The number of adenocarcinoma test images in which 1 or more malignant cells were detected was 2710 of 2731. The sensitivity in the nonadenocarcinoma dataset was 97.1%, and the false-positive rate in the negative-for-malignancy dataset was 7.3%. The accuracy, sensitivity, and specificity of the model using all the test datasets were 96.3%, 98.5%, and 92.7%, respectively.</p><p><strong>Conclusions: </strong>Although some issues regarding cell annotation when creating an object detection model remain, the accuracy is sufficient to assist cancer screening in effusion cytology. It is vital to reliably detect malignant cells in effusion cytology, and the further development of automated systems to reduce false-negative results is expected.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"415-423"},"PeriodicalIF":1.9000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of clinical pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajcp/aqaf067","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Cytologic examination, which confirms the presence or absence of malignant cells, detects malignant cells from various organs, with adenocarcinoma as the most common histologic type. We developed a deep learning model to detect malignant cells in images obtained following effusion cytology.
Methods: The deep learning model was created using the YOLOv8 object detection algorithm (Roboflow, Inc) and 275 cases of adenocarcinoma comprising 12 182 images and 29 245 labels as well as 188 cases negative for malignancy comprising 1980 images.
Results: The adenocarcinoma test dataset exhibited Precision, Recall, F1, and mean average Precision scores of 0.909, 0.911, 0.910, and 0.955, respectively. The number of adenocarcinoma test images in which 1 or more malignant cells were detected was 2710 of 2731. The sensitivity in the nonadenocarcinoma dataset was 97.1%, and the false-positive rate in the negative-for-malignancy dataset was 7.3%. The accuracy, sensitivity, and specificity of the model using all the test datasets were 96.3%, 98.5%, and 92.7%, respectively.
Conclusions: Although some issues regarding cell annotation when creating an object detection model remain, the accuracy is sufficient to assist cancer screening in effusion cytology. It is vital to reliably detect malignant cells in effusion cytology, and the further development of automated systems to reduce false-negative results is expected.
期刊介绍:
The American Journal of Clinical Pathology (AJCP) is the official journal of the American Society for Clinical Pathology and the Academy of Clinical Laboratory Physicians and Scientists. It is a leading international journal for publication of articles concerning novel anatomic pathology and laboratory medicine observations on human disease. AJCP emphasizes articles that focus on the application of evolving technologies for the diagnosis and characterization of diseases and conditions, as well as those that have a direct link toward improving patient care.